Organon (OGN) Capital Expenditures (2020 - 2026)

Organon (OGN) has reported Capital Expenditures for 7 consecutive years, with $37.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures rose 15.62% year-over-year to $37.0 million; the TTM figure through Mar 2026 stood at $167.0 million (up 3.73% YoY), while the FY2025 annual figure was $162.0 million, down 7.43% from the prior year.
• Capital Expenditures came in at $37.0 million for Q1 2026 at Organon, down from $45.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $79.0 million in Q4 2023, with the low at $32.0 million in Q2 2024.
• Average Capital Expenditures over 5 years is $48.3 million, with a median of $46.0 million recorded in 2023.
• Across the five-year window, Capital Expenditures soared 57.78% in 2023 and plunged 54.93% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $63.0 million in 2022, then increased by 25.4% to $79.0 million in 2023, then tumbled by 30.38% to $55.0 million in 2024, then decreased by 18.18% to $45.0 million in 2025, then fell by 17.78% to $37.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $37.0 million, $45.0 million, and $46.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.